Akers Biosciences Inc PE Ratio 2012-2019 | AKER

Current and historical p/e ratio for Akers Biosciences Inc (AKER) from 2012 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Akers Biosciences Inc PE ratio as of December 05, 2019 is 0.00.
Akers Biosciences Inc PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-06 3.01 0.00
2019-09-30 0.44 $-12.95 0.00
2019-06-30 0.45 $-17.51 0.00
2019-03-31 0.97 $-19.90 0.00
2018-12-31 1.13 $-23.98 0.00
2018-09-30 2.27 $-59.95 0.00
2018-06-30 3.10 $-78.66 0.00
2018-03-31 6.64 $-90.17 0.00
2017-12-31 1.07 $-120.86 0.00
2017-09-30 6.48 $-115.11 0.00
2017-06-30 10.00 $-78.66 0.00
2017-03-31 14.40 $-99.76 0.00
2016-12-31 15.20 $-117.03 0.00
2016-09-30 26.87 $-211.03 0.00
2016-06-30 25.76 $-308.87 0.00
2016-03-31 13.44 $-351.08 0.00
2015-12-31 9.68 $-347.24 0.00
2015-09-30 25.20 $-251.32 0.00
2015-06-30 34.80 $-209.11 0.00
2015-03-31 33.92 $-149.64 0.00
2014-12-31 31.92 $-126.62 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $0.002B
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.637B 27.48
Medtronic (MDT) Ireland $150.042B 20.73
Stryker (SYK) United States $76.456B 25.71
Boston Scientific (BSX) United States $59.948B 28.30
Baxter (BAX) United States $42.085B 25.52
Essilor Luxottica (ESLOY) France $33.039B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.517B 19.15
Terumo (TRUMY) Japan $27.707B 34.58
Coloplast (CLPBY) Denmark $25.466B 39.30
Lonza Group Ag (LZAGY) Switzerland $25.140B 0.00
ResMed (RMD) United States $21.589B 39.83
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.307B 537.91
Bio-Rad Laboratories (BIO) United States $11.116B 53.36
DiaSorin S.p.A (DSRLF) Italy $7.580B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.111B 20.97
Perrigo (PRGO) Ireland $6.899B 12.86
Canopy Growth (CGC) Canada $6.407B 0.00
Haemonetics (HAE) United States $6.041B 40.82
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.822B 30.09
ICU Medical (ICUI) United States $3.799B 24.77
Neogen (NEOG) United States $3.543B 59.28
GW Pharmaceuticals (GWPH) United Kingdom $3.272B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.243B 0.00
Quidel (QDEL) United States $2.849B 27.04
Aurora Cannabis (ACB) Canada $2.702B 0.00
Agios Pharmaceuticals (AGIO) United States $2.371B 0.00
National Vision Holdings (EYE) United States $2.367B 53.43
Cardiovascular Systems (CSII) United States $1.555B 0.00
InMode (INMD) Israel $1.371B 0.00
Aphria (APHA) $1.175B 0.00
AtriCure (ATRC) United States $1.173B 0.00
VAREX IMAGING (VREX) United States $1.161B 23.26
Phibro Animal Health (PAHC) United States $0.983B 18.41
NanoString Technologies (NSTG) United States $0.953B 0.00
TG Therapeutics (TGTX) United States $0.816B 0.00
Lantheus Holdings (LNTH) United States $0.793B 19.80
Eagle Pharmaceuticals (EGRX) United States $0.762B 29.17
Omeros (OMER) United States $0.758B 0.00
LeMaitre Vascular (LMAT) United States $0.719B 40.44
Quanterix (QTRX) United States $0.689B 0.00
PetIQ (PETQ) United States $0.644B 15.72
Cerus (CERS) United States $0.587B 0.00
Surmodics (SRDX) United States $0.553B 57.44
HEXO (HEXO) $0.548B 0.00
OraSure Technologies (OSUR) United States $0.476B 28.56
MacroGenics (MGNX) United States $0.473B 0.00
Owens & Minor (OMI) United States $0.439B 16.23
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.61
Meridian Bioscience (VIVO) United States $0.389B 13.37
Zynex (ZYXI) United States $0.341B 38.52
BioLife Solutions (BLFS) United States $0.332B 135.17
Bovie Medical (APYX) United States $0.271B 0.00
United Health Products (UEEC) United States $0.263B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Viemed Healthcare (VMD) United States $0.230B 24.28
Vapotherm (VAPO) United States $0.223B 0.00
Liberty Health Sciences (LHSIF) Canada $0.187B 0.00
Repro-Med Systems (KRMD) United States $0.187B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
InfuSystems Holdings (INFU) United States $0.158B 796.00
Chimerix (CMRX) United States $0.155B 0.00
Female Health (VERU) United States $0.142B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
MTech Acquisition (KERN) United States $0.128B 0.00
Fonar (FONR) United States $0.127B 8.92
Cytosorbents (CTSO) United States $0.122B 0.00
United-Guardian (UG) United States $0.092B 23.27
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00